chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received my second Pfizer booster for COVID-19 on 4/11/2022. I'm not entirely sure on which days these events happened, but sometime in July 2022, I was exposed to COVID-19 at a family reunion. I tested myself twice with home antigen tests. I got a negative result the first time and a positive result the second time. I didn't really develop any symptoms other than maybe fatigue. I was prescribed PAXLOVID, which I took. Even though I felt fine, I self-isolated to avoid possibly spreading the virus to others. I'm not sure, but I think the isolation was during the week of 7/10/2022-7/16/2022.
This spontaneous report was received from a health care worker concerning an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On unspecified dates, the patients were vaccinated with improperly stored doses of VARIVAX injection (dose, strength, and route of administration were not reported) (lot # M028553, expiration date 07-JUN-2018) for prophylaxis. According to the reporter, VARIVAX doses were exposed to the following temperatures excursions: 2 hours and 20 minutes between >-15 degrees Celsius (C) and <-10 C. No adverse effects were reported. A digital data logger was involved. Additional information has been requested.
Diarrhea; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and PYREXIA (Fever) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M2UA) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction (No medical history reported.).    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DIARRHOEA (Diarrhea) and PYREXIA (Fever). On 02-Mar-2021, PYREXIA (Fever) had resolved. At the time of the report, DIARRHOEA (Diarrhea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Vaccine was given in left arm on 3/13/08.  On 3/15/08 (Saturday) we noticed patient's arm was very swollen from the sight of injection all the way down to forearm.  The area was red and hot and hard to the touch.  We brought him to emergency room and he was immediately admitted and kept for 2 days.  He was given IV antibiotics. By Sunday night the arm was less swollen. His  bloodwork done on Saturday was OK. His 24 and 48 hour blood cultures were negative.  His diagnosis was cellulitis, but the discharge doctor felt that with all the negative tests results that it may have been a reaction to the vaccine.  04/14/2008 MR received for ER admit 3/15/08 with Assessment: Post injection Right Shoulder Cellulits vs Local Reaction. Child presented to Er with 2 day hx of swelling, erythema, and tenderness of the R shoulder area. PE (+) for erythema, induration, swelling and tenderness from the shoulder to the elbow. R axillary node enlargement. Admitted for IV abx.
Chills fever, ears felt funny, aches, swollen red and sore arm.  Rash still present on arm and itchy. Symptoms are now better. Took Tylenol only and rested. Very tired for 3 days
Information has been received from a consumer concerning her approximate 14 month old daughter with no drug allergy who on 31-MAR-1999 was vaccinated with the first dose of MMR II vaccine (lot number not provided). Subsequently the patient experienced fever over 105 degrees Fahrenheit for at least 7 days after getting MMR II vaccine. The patient was recovering. The patient did not seek medical attention. No further information is available.
TESTED POSITIVE FOR COVID; This spontaneous report received from a patient concerned a 24 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: PSOO30539 expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 24-FEB-2022, the patient experienced tested positive for covid. Laboratory data included: COVID-19 antigen test (NR: not provided) tested positive twice. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of tested positive for covid was not reported. This report was non-serious.
feeling pain on the left side of [their] arm where [they] got the shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 51 year-old female patient received bnt162b2 (BNT162B2), administration date 15Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "feeling pain on the left side of [their] arm where [they] got the shot".  Additional information: The patient was asked if they could take Ibuprofen or Tylenol for the pain after vaccination. The patient was concerned that if he takes those medications, they could create some problem with the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021289826 same reporter/product/event, different patient.
Infanrix was given to an 11 year old patient instead of a dose of Boostrix; Infanrix was given to an 11 year old patient instead of a dose of Boostrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of underdose in a 11-year-old male patient who received DTPa (Infanrix) (batch number 7HM5J, expiry date 13-SEP-2024) for prophylaxis.   On 10-OCT-2023, the patient received Infanrix. On 10-OCT-2023, an unknown time after receiving Infanrix, the patient experienced underdose (Verbatim: Infanrix was given to an 11 year old patient instead of a dose of Boostrix) and inappropriate age at vaccine administration (Verbatim: Infanrix was given to an 11 year old patient instead of a dose of Boostrix). The outcome of the underdose and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 18-OCT-2023 The medical assistant reported that a dose of Infanrix was given to an 11 year old patient instead of Boostrix which led to inappropriate age at vaccine administration and underdose. The reporter consented to follow up.
Information has been received from a nurse referring to a 12 month old patient. On 15-JUL-2016 the patient was inadvertently vaccinated with a dose of PROQUAD (Lot # L032761, exp date 24-FEB-2017) and a dose of expired VARIVAX (lot # K009758, expiration date 09-JUL-2016, route not reported) (accidental overdose). The nurse explained that the patient was actually in the office to receive a dose of VARIVAX and a dose of M-M-R II, however, the PROQUAD was inadvertently administered instead of the M-M-R II because the labels on both vials were very similar and the unknown health care worker only saw that the vial read Measles Mumps Rubella and did not see the label also stated Varicella on the vial of the PROQUAD until after the administration. No adverse effects were reported. Additional information has been requested.
Site of injection was hot; Site of injection has red rash; Feels pain when she touch the area of site of injection; Pain in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the left arm), VACCINATION SITE WARMTH (Site of injection was hot), VACCINATION SITE RASH (Site of injection has red rash) and VACCINATION SITE PAIN (Feels pain when she touch the area of site of injection) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in the left arm). On 29-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Site of injection was hot), VACCINATION SITE RASH (Site of injection has red rash) and VACCINATION SITE PAIN (Feels pain when she touch the area of site of injection). At the time of the report, PAIN IN EXTREMITY (Pain in the left arm), VACCINATION SITE WARMTH (Site of injection was hot), VACCINATION SITE RASH (Site of injection has red rash) and VACCINATION SITE PAIN (Feels pain when she touch the area of site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
This spontaneous report as received from the nurse refers unspecified number of patients of unspecified age and gender. Medical history and concurrent conditions were not reported. In 2015 (reported as unspecified dates since 04-MAY-2015), the patients were vaccinated with VAQTA (lot number: K010579 and expiry date: 12-FEB-2017) (dose, frequency and route of administration were not reported) which was exposed to temperatures outside of the recommended range. No adverse effects have been reported. The outcome of the reported event was unknown. The causality of the suspected product was considered to be not related to the event. No product quality complaint (PQC) was filed. No additional information was provided. This is one of several reports from the same reporter. Additional information has been requested.
broke out w/a rash on arms about 1030PM day of vax; w/in 15 mins entire body was covered w/rash; also exp chills, fever, gen'l aching, extreme lethargic; went to ER-t102;
She felt fine after the vaccine, waiting 30 minutes, got home and was fine.  the next morning when she woke up at her usual time everything hurt.  Her arm had a swelling on it, and was pretty sore where she received the shot.  Every ache or pain that she ever had was screaming at her and every time she tried to move she screamed in pain.  On her right back it felt like it was broken, so painful to move.  Her husband pulled her out of the bed to get up, help her make dinner.  It did not go away all day, just awful until she fell asleep at night.  She continued to take Tylenol throughout the day.  When she woke up this morning she was back to normal except for her arm that is still a little sore.
Legs started swelling and shortness of breath Thursday January 21 2021 Was rushed to hospital with kidney failure and fluid build up around lungs and entire body Blood pressure dropped and had multiple organ failure
painful, swollen lymph nodes in armpit of right arm. feeling much better today, 3-8-21, but pain not completely gone. ibuprofen and acetominophen used to treat.
muscle/body aches/chills, feeling feverish, nausea, headache, lightheaded. Ibuprofen and acetaminophen alternating every 2-3 hours helped reduce severity of symptoms. Had to leave work due to symptoms.
The night, post vax, pt had a low grade fever and emesis. The next day, the fever was up to 102 with decreased appetite and emesis.
Had a little bit more than normal soreness in the shoulder, felt like bruising.  The day after the injection started getting flu symptoms, fairly severe, fever, coughing, runny nose, no energy at all.  Felt like he had a the worst case of flu he ever had.  He is getting better, but still has some of the symptoms.  The only thing he has taken for it is Nyquil and took a Sinutab.   Did have nausea, diarrhea, everything that comes with the flu.  Sinuses are drying up, energy is coming back and able to eat again.  He did call his doctor and he recommended that he call us and report this event.  He did have to postpone a procedure that he was scheduled for on Monday.
Numbness starting/worse in feet, extending up legs to chest. Incontinence. Poor balance, unsteady gait, two falls. Treatment w steroids and physical therapy (hosp.).
Flu-like symptoms within 12 hours: slight fever, headache, chills, body aches.
pneumonia; I have experienced my heart pumping; severe pain; coughing; chills; continuous fever.; This spontaneous case was reported by a patient and describes the occurrence of PNEUMONIA (pneumonia) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PNEUMONIA (pneumonia) (seriousness criterion medically significant), PALPITATIONS (I have experienced my heart pumping), PAIN (severe pain), COUGH (coughing), CHILLS (chills) and PYREXIA (continuous fever.). At the time of the report, PNEUMONIA (pneumonia), PALPITATIONS (I have experienced my heart pumping), PAIN (severe pain), COUGH (coughing), CHILLS (chills) and PYREXIA (continuous fever.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient returned to Pharmacy approximately 20 minutes after admnistration. He stated that his arm felt really sore, and he had tingling/numbness in his hand on the same side that he received his vaccine. No outward signs of Anaphylaxis, had patient remain under observation for approximately 20 more minutes after which time patient stated that his arm felt slightly better but still had that "tingling" feeling. He said it wasn't worsening or spreading. I counseled patient to seek additional medical care with primary care physician within the next 3 days even if the sensation goes away, and strongly recommended going to an ER immediately if he experiences any increase/ worsening of symptoms.  I also asked patient to follow up with as and informed him that I would submit a VAERs report.
By 6:30 pm the same rash was on both outer sides of my legs again splotchy raised and itchy; Bumpy itchy rash on my knees at noontime on Friday the 12th; This is a spontaneous report from a contactable other hcp (patient herself). A 42-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and Expiration date were not reported) via an unspecified route of administration, administered in arm left on 10Feb2021 09:45 (age at the vaccination 42-year-old) as dose number unknown, single for COVID-19 immunization (Doctor's office/urgent care). Medical history included systemic lupus, celiac disease from an unknown date and unknown if ongoing and known allergies all sulphate drugs and penicillin an unknown date and unknown if ongoing. Concomitant medications included atomoxetine hydrochloride (STRATTERA), citalopram hydrobromide (CELEXA [CITALOPRAM HYDROBROMIDE]) taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant at time of vaccination. On 12Feb2021 12:00, the patient had experienced bumpy itchy rash on my knees at noon time on Friday the 12th, by 6:30 pm the same rash was on both outer sides of my legs again splotchy raised and itchy. The patient did not receive treatment for the adverse events. The patient had not received any other vaccine within four weeks. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since post vaccination. The outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
4/15/22 pt presented to ED with fever, nausea, generalized weakness, and shaking spells x past 24 hrs; found to have a UTI and positive for COVID; treated with dexamethasone, Vitamins C & D; not a candidate for remdesivir; suffered cardiac arrest twice, 2 minutes each before ROSC was achieved; intubated; family decided to transition to comfort measure; pt expired in the hospital
In April I started experiencing a cardiac arrhythmia that was different than my usual SVT. It was accompanied by shortness of breath and visual disturbance.
Pt started feeling queasy and nauseous the day after having HPV. Vomited x 1
Facial swelling 20-30 minutes after injections was advised to return to office and treated with Zyrtec and Orapred.
I was pregnant at the time of the vaccination and had an uncomplicated delivery on May 12 (7 lbs 10 oz). Early July I experienced joint pain in my hands and feet. In September I was diagnosed with rheumatoid arthritis. The joint pain continued to worsen. I had a severe flare after getting the booster on November 12.
2nd dose missed; This non-serious case was reported by a physician via sales rep and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: 2nd dose missed). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 04-MAY-2023 The reporter asked that if the second dose was missed would the patient had to start over with the first dose. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Patient admitted with abdominal pelvic pain - CT scan of the abdomen and pelvis revealed perforated appendicitis with 7 cm abscess. She was admitted to the hospital for further management. She was started on IV Flagyl and ceftriaxone at the time of admission. Patient underwent guided percutaneous drainage catheter placement. 70 ml of sanguinopurulent fluid was aspirated and pain improved and her leukocytosis resolved. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Covid arm.  Hot red itchy welt at the site of the injection. About the size of a half baseball.  Neck ache, shoulder ache, headache, burning sensation in and down my entire left arm and settling in the top of my hand that has not gone away.  The same thing happened with my first injection, (hot red, itchy welt at the injection site, which even a month later has left a large dollar coin-sized discoloration in my arm.) Minus the burning sensation, the neck ache, and shoulder ache.   This time, with the second dose I have all of that and more. The burning sensation in the top of my hand is terrible. combined with the neck ache, shoulder ache, and headache, I can't seem to get comfortable enough to sleep at night or type well without having to stop every few moments and rub my hand to make the sensation go away.  The burning I felt right away with the injection. The first dose I got on  9/28/21 (lot number 006c21a)  didn't burn at all. The second shot burned a lot, and it only got worse as time went on.
Saturday morning on her right thigh noticed swelling and a big red welt, probably about 3cm x 1 cm. (Received Prevnar 13 here).  Sat. AM noticed one giant, red raised welt on her back, almost covering the entire back.  Gave Benadryl 12.5 mg x 1 and Tylenol and it did get better, not completely resolved.  Daycare called and said its on her back and stomach now.
Patient developed a rash on his face Tuesday morning. Rash isn't spreading and is not itching. Recommended Benadryl to help with the rash. Advised to see a doctor if it spreads/gets worse or if it had not gone away by next week.
Fever, chills, headache, nausea, vomiting, body aches, weakness, soreness at site of injection. Unable to drink anything. Attempted to take Advil twice and vomited both times.
MIGRAINE; RESTLESS NIGHT AND DAY IN BED; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced migraine, and restless night and day in bed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the migraine and restless night and day in bed was not reported. This report was non-serious. This case, from the same reporter is linked to 20210428170.
Mild depression requiring physician visit. Currently treating with 10 mg citalopram and counseling.
Administration error : Patient under 18 received Moderna vaccination (1st and 2nd dose) instead of Pfizer.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concurrent conditions, medical history, or concomitant medications.   On or about 25-AUG-2012, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location of vaccine, lot # and expiration date were not provided) for routine maintenance and for its intended purpose: the prevention of shingles (herpes zoster).  On an unspecified date, subsequent to patient's dose zoster vaccine live (ZOSTAVAX) inoculation, the patient presented shingles. At the reporting time, the outcome for the event was unknown.   The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
1/18 - 1/19: swollen, red, painful, and itchy injection site, but subsided completely three days after shot.  1/24 ~9PM: under injection site swelled up (hard) again, warm to the touch, and very itchy.
Fatigue, Muscle pain, Joint pain, Chills and Strong smelling urine.  Was down and out entire day after vaccine.  Off and on symptoms on 2nd day after vaccine.
This is a spontaneous report from a physician referring to a 40 year old main who, on 5/23/99, the pt received his 1st Lymerix dose in left deltoid, IM. Subsequently, he experienced nausea and muscle aches. Outcome; resolved. On 6/23/1999, the pt received his 2nd dose, IM, left deltoid. Within hours, on 6/23/1999, he experienced nausea, fatigue and muscle aches. Symptoms resolved spontaneously. The most recent information, received on 7/15/1999, reports the condition of the pt is resolved.
Days 2-4 after vaccine:  body ache, tiredness, occasional headache, muscle pain where shot was administered on first day Days 6-7: light cough, stuffy nose Days 8-14: Tired, itchy eyes, foggy headed, intermittent headaches,